Twitter

A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)

Condition:   Glioblastoma
Interventions:   Drug: Hydroxychloroquine;   Radiation: Radiotherapy
Sponsors:   University College, London;   University College, London;   Cancer Research UK
Not yet recruiting – verified May 2012

Read more here: A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)




Comments are closed.